ZA956831B - 3-Substituted-2-oxindoles as inhibitors of viral replication. - Google Patents

3-Substituted-2-oxindoles as inhibitors of viral replication.

Info

Publication number
ZA956831B
ZA956831B ZA9506831A ZA956831A ZA956831B ZA 956831 B ZA956831 B ZA 956831B ZA 9506831 A ZA9506831 A ZA 9506831A ZA 956831 A ZA956831 A ZA 956831A ZA 956831 B ZA956831 B ZA 956831B
Authority
ZA
South Africa
Prior art keywords
oxindoles
inhibitors
substituted
viral replication
replication
Prior art date
Application number
ZA9506831A
Other languages
English (en)
Inventor
Sandra L Silberman
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA956831B publication Critical patent/ZA956831B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9506831A 1994-08-17 1995-08-16 3-Substituted-2-oxindoles as inhibitors of viral replication. ZA956831B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29213894A 1994-08-17 1994-08-17

Publications (1)

Publication Number Publication Date
ZA956831B true ZA956831B (en) 1997-02-17

Family

ID=23123389

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9506831A ZA956831B (en) 1994-08-17 1995-08-16 3-Substituted-2-oxindoles as inhibitors of viral replication.

Country Status (8)

Country Link
JP (1) JPH0859464A (ja)
KR (1) KR960006923A (ja)
CN (1) CN1123144A (ja)
AU (1) AU2859495A (ja)
CA (1) CA2156120A1 (ja)
HU (1) HUT73810A (ja)
IL (1) IL114891A0 (ja)
ZA (1) ZA956831B (ja)

Also Published As

Publication number Publication date
CA2156120A1 (en) 1996-02-18
JPH0859464A (ja) 1996-03-05
HUT73810A (en) 1996-09-30
CN1123144A (zh) 1996-05-29
IL114891A0 (en) 1995-12-08
AU2859495A (en) 1996-02-29
KR960006923A (ko) 1996-03-22
HU9502420D0 (en) 1995-10-30

Similar Documents

Publication Publication Date Title
DE69533256D1 (en) Chimäre komplement inhibitor proteine
PL331900A1 (en) 1,4-heterocyclic inhibitors of metaloprotease
PL331838A1 (en) 1,3-diheterocyclic inhibitors of metaloproteases
PL322584A1 (en) Inhibitors of proteinous kinase c
PL326754A1 (en) Inhibitors of proteinous kinase c
ZA9710322B (en) Process for the preparation of benzyl-ethers.
IL109963A0 (en) E2-f1 enzyme and methods for the isolation, purification and use thereof
AU6774294A (en) Methods of preventing viral replication
EP0567088A3 (en) Process for the preparation of an amylase inhibitor.
EP0630245A4 (en) PROTEIN KINASE C INHIBITOR.
AU3107795A (en) Inhibitors of the benzamidine type
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
AU3877095A (en) Modified proteinase inhibitors
PL319905A1 (en) Apolipoprotein b synthesis inhibitors
ZA975986B (en) N-alkoxyadenine derivatives acting as cytokine inhibitors.
GB9425701D0 (en) Enzyme inhibitors
PL320190A1 (en) Novel, physically stable form of fuoroquinolone
AU4248297A (en) Inhibition of viral replication
HU9503783D0 (en) Squvalen syntetase inhibitors
CY2392B1 (en) Method for the preparation of alpha-bromolactam derivatives.
EP0669361A3 (en) Process for the preparation of polyheterosiloxanes.
GB9515802D0 (en) Hiv protease inhibitors useful for the treatment of aids
AU6378598A (en) Method for inhibition of virus replication
ZA982255B (en) Process for the preparation of arylmalonates.
EP0682034A3 (en) Process for the preparation of cyanoalkylorganooxysilanes from cyanoalkylchlorosilanes.